Interactomics in Neurodegeneration

Interactomics is the intersection of bioinformatics and biology concerned with investigating the interaction and the consequences of these interactions between proteins in a cell. Here is the latest research on interactomic data in neurodegeneration.

January 19, 2021

A systematic review of synthetic tyrosinase inhibitors and their structure-activity relationship

Critical Reviews in Food Science and Nutrition
Zhiyun PengYong Zhao
January 16, 2021

Effect of lipase incorporation on gelling properties of catfish (Clarias lazera) surimi and its mechanism

Journal of the Science of Food and Agriculture
Xidong JiaoDaming Fan
January 19, 2021
Preprint
Open Access

Kinetic analysis of ASIC1a delineates conformational signaling from proton sensing domains to the channel gate

BioRxiv : the Preprint Server for Biology
S. VulloStephan Kellenberger
January 3, 2021

Plant miR171 modulates mTOR pathway in HEK293 cells by targeting GNA12

Molecular Biology Reports
Angelo GismondiAntonella Canini
December 31, 2020

Immunological, histopathological, and ultrastructural evidence of steroid-induced reactivation of chronic murine toxoplasmosis

Ultrastructural Pathology
Aida A Abdel-MagiedNora I Aboulfotouh
January 13, 2021
Preprint
Open Access

Proton magnetic resonance spectroscopy in frontotemporal lobar degeneration-related syndromes

MedRxiv : the Preprint Server for Health Sciences
Alexander G MurleyJ. B. Rowe
January 7, 2021
Preprint
Open Access

The dysregulated Pink1- Drosophila mitochondrial proteome is partially corrected with exercise.

BioRxiv : the Preprint Server for Biology
B. EbanksLisa Chakrabarti
January 1, 2021
Review
Open Access

The Convergence of Alpha-Synuclein, Mitochondrial, and Lysosomal Pathways in Vulnerability of Midbrain Dopaminergic Neurons in Parkinson's Disease

Frontiers in Cell and Developmental Biology
Georgia MinakakiLena F Burbulla
January 8, 2021
Open Access

Connecting the αα-hubs: same fold, disordered ligands, new functions

Cell Communication and Signaling : CCS
Lasse StabyBirthe B Kragelund
December 31, 2020
Open Access

The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis

Molecular Biology of the Cell
Shalini MenonStephanie L Gupton
January 17, 2021
Review
Open Access

Implication of Contactins in Demyelinating Pathologies

Life
Ilias KalafatakisDomna Karagogeos
January 8, 2021
Open Access

Synaptosomes: new vesicles for neuronal mitochondrial transplantation

Journal of Nanobiotechnology
Pasquale PiconeMarta Di Carlo

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/interactomics-in-neurodegeneration/000962a8-a1af-4a80-8ca7-a840cba38fc7